2025-06-09-花旗集团-慧择控股有限公司（HUIZ）_慧择控股有限公司（HUIZ.O）_业绩_2025年第一季度因海外扩张导致利润率侵蚀而转为亏损；评级下调至中性_高风险_14页_612kb

Summary of Huize Holding Ltd (HUIZ.O) Analysis

• Company Overview: Huize Holding Ltd is an independent online insurance broker in China, focusing on distributing long-term life insurance products through its platform. It has expanded internationally, facilitating over Rmb3.421 billion in premiums in 2024.

• Financial Performance (Q1 2025):

  • The company reported a net loss of Rmb8.6 million, down from a profit of Rmb6.9 million in Q1 2024, primarily due to margin erosion amid overseas expansion.
  • Revenue decreased by 9% year-over-year. Brokerage income fell 10% YoY, dragged by a 16% contraction in gross premiums, while the blended commission rate improved slightly to 18.9%. Gross profit declined 19% YoY to Rmb73.3 million.
  • Margins narrowed due to challenges in overseas markets, offset partly by increased marketing expenses driving higher selling costs.

• Citigroup's Analysis and Rating:

  • The firm downgraded Huize to Neutral/High Risk from Buy/High Risk, citing unfavorable geographic shifts that could continue pressing business margins.
  • Target price reduced to US$2.30 from previous levels. Citigroup cut its 2025E/2026E adjusted earnings forecasts by 63%/39% to Rmb7.3 million/Rmb17.3 million.
  • Positive outlook: Overseas business may surge in Q2 2025 due to pre-regulatory changes, potentially boosting short-term momentum.

• Future Outlook and Expansion Plans:

  • Management aims to increase overseas revenue contribution to 30% by 2026, with expansions into Singapore (planned for Q3 2025) and the Philippines (targeting 2H 2025).
  • Internationally, Vietnam (Q1 2025) showed strong growth in premiums and revenue.

• Key Risks and Valuation:

  • Downside risks: Margin erosion, stringent regulations on insurance intermediaries, and potential shareholder changes. Upside catalysts: Market rally, regulatory easing on commissions, or reduced channel costs.
  • Valuation: Target price US$2.30 based on DCF with a WACC of 20.7%. Current P/E and P/B ratios are low but reflect the high risk. Expected total return is 13.3%.

• Additional Notes:

  • The company maintains an asset-light model with stable revenue from long-term health products, but overseas expansion is expected to strain margins.
  • Citigroup has disclosures of potential conflicts of interest and affiliations with Huize.

This summary captures the core elements of the 1Q25 financial review and Citigroup's recommendations.